Abstract Library

#4611 Management strategies and outcomes for type 1 gastric neuroendocrine tumours measuring > 1cm in diameter

Introduction: Although type 1 gastric neuroendocrine tumours (T1-gNETs) are usually considered indolent diseases, the management and the outcome of tumours >1cm remain not well established.

Conference:

Presenting Author:

Authors: Dell' Unto E, Srirajaskanthan R, Saini A, Salin G, de Mestier L,

Keywords: gastric neuroendocrine tumour, gastric carcinoid, endoscopic treatment,

#4080 Synchronous case of advanced gastric Her-2 + adenocarcinoma and metastatic neuroendocrine neoplasm of unknown origin – A MiNEN case?

Introduction: Gastric adenocarcinoma case treated with capecitabine and trastuzumab. After surgery, a G2 neuroendocrine tumor was found.

Conference:

Presenting Author:

Authors: Jimenez Gordo A, Gomez Raposo C, Garcia-Sancho Tellez L, Salinas Moreno S, Madrid Vallenilla A,

Keywords: MiNEN, clonal selection, citostatic treatment,

#3783 Impact on clinical management of a novel blood-derived liquid biopsy (NETest) in patients with neuroendocrine tumors

Introduction: Despite progresses in NET management, there are persisting challenges regarding initial diagnosis, treatment response assessment and disease follow-up.

Conference:

Presenting Author: Chirindel A

Authors: Chirindel A, de Dosso S, Wild D, Siebenhüner A, Voegeli M,

Keywords: transcriptomics, biomarker, NETest, clinical management, NET,

#3697 Radiological embolization of liver metastases in patients with pancreatic neuroendocrine neoplasms

Introduction: Pancreatic neuroendocrine neoplasms (pNEN) may present with liver metastases at diagnosis, often bilobar (LM). Radiological embolization (RE) of LM is one of the treatment options.

Conference:

Presenting Author: Milanetto A

Authors: Milanetto A, David A, Ponzoni A, Pasquali C,

Keywords: embolization, ablation, metastasis, pancreatic NET,